Johnson RK - Search Results

1

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.

Burris HA 3rd, Hanauske AR, Johnson RK, Marshall MH, Kuhn JG, Hilsenbeck SG, Von Hoff DD. Burris HA 3rd, et al. Among authors: johnson rk. J Natl Cancer Inst. 1992 Dec 2;84(23):1816-20. doi: 10.1093/jnci/84.23.1816. J Natl Cancer Inst. 1992. PMID: 1331485

2

New anticancer agents.

Weiss GR, Burris HA, Eckardt JR, Fields S, Johnson R, O'Rourke T, Rodriguez GI, Rothenberg ML, Wall J. Weiss GR, et al. Cancer Chemother Biol Response Modif. 1993;14:118-28. Cancer Chemother Biol Response Modif. 1993. PMID: 8312101 Review. No abstract available.

3

Pharmacokinetics and pharmacodynamics of topotecan in patients with advanced cancer.

Grochow LB, Rowinsky EK, Johnson R, Ludeman S, Kaufmann SH, McCabe FL, Smith BR, Hurowitz L, DeLisa A, Donehower RC, et al. Grochow LB, et al. Drug Metab Dispos. 1992 Sep-Oct;20(5):706-13. Drug Metab Dispos. 1992. PMID: 1358575

4

Nonclinical pharmacokinetics and activity of etirinotecan pegol (NKTR-102), a long-acting topoisomerase 1 inhibitor, in multiple cancer models.

Hoch U, Staschen CM, Johnson RK, Eldon MA. Hoch U, et al. Among authors: johnson rk. Cancer Chemother Pharmacol. 2014 Dec;74(6):1125-37. doi: 10.1007/s00280-014-2577-7. Epub 2014 Sep 17. Cancer Chemother Pharmacol. 2014. PMID: 25228368 Free PMC article.

5

Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis.

Budman DR, Johnson R, Barile B, Bowsher RR, Vinciguerra V, Allen SL, Kolitz J, Ernest CS 2nd, Kreis W, Zervos P, Walling J. Budman DR, et al. Cancer Chemother Pharmacol. 2001 Jun;47(6):525-31. doi: 10.1007/s002800000272. Cancer Chemother Pharmacol. 2001. PMID: 11459206 Clinical Trial.

6

Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region.

Jacoby E, Quan D, Todd E, Shortt J, Smith H, Rafaels N, Crooks K; CCPM biobank Author Banner list. Jacoby E, et al. Muscle Nerve. 2025 Feb;71(2):252-256. doi: 10.1002/mus.28301. Epub 2024 Dec 10. Muscle Nerve. 2025. PMID: 39655870

7

Shifting from a female-dominated profession: The perceptions and experiences of male students in communication sciences and disorders.

Johnson RK, Puhlman J, Puhlman DJ. Johnson RK, et al. J Commun Disord. 2024 Nov-Dec;112:106474. doi: 10.1016/j.jcomdis.2024.106474. Epub 2024 Oct 28. J Commun Disord. 2024. PMID: 39489027

8

Maternal Serum Metabolomics in Mid-Pregnancy Identifies Lipid Pathways as a Key Link to Offspring Obesity in Early Childhood.

Francis EC, Kechris K, Johnson RK, Rawal S, Pathmasiri W, Rushing BR, Du X, Jansson T, Dabelea D, Sumner SJ, Perng W. Francis EC, et al. Among authors: johnson rk. Int J Mol Sci. 2024 Jul 11;25(14):7620. doi: 10.3390/ijms25147620. Int J Mol Sci. 2024. PMID: 39062861 Free PMC article.

9

Precision treatment of beta-cell monogenic diabetes: a systematic review.

Naylor RN, Patel KA, Kettunen JLT, Männistö JME, Støy J, Beltrand J, Polak M; ADA/EASD PMDI; Vilsbøll T, Greeley SAW, Hattersley AT, Tuomi T. Naylor RN, et al. Commun Med (Lond). 2024 Jul 18;4(1):145. doi: 10.1038/s43856-024-00556-1. Commun Med (Lond). 2024. PMID: 39025920 Free PMC article.

10

Longitudinal changes in DNA methylation during the onset of islet autoimmunity differentiate between reversion versus progression of islet autoimmunity.

Carry PM, Vanderlinden LA, Johnson RK, Buckner T, Steck AK, Kechris K, Yang IV, Fingerlin TE, Fiehn O, Rewers M, Norris JM. Carry PM, et al. Among authors: johnson rk. Front Immunol. 2024 Jun 10;15:1345494. doi: 10.3389/fimmu.2024.1345494. eCollection 2024. Front Immunol. 2024. PMID: 38915393 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

495 results

Search Page

Filters